This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digital HealthTechnologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. Another example is CliniScout Recruit by Healthware – a digital service for recruiting subjects to clinical trials.
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the healthtechnology, health services, medical device, and life sciences sectors. MDisrupt has raised $6.6
BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital healthtechnology and develop digital biomarkers for Parkinson’s disease.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. About VivoSense VivoSense, Inc.
My name is Rachel Francine and I am the co-founder and CEO of musical healthtechnologies, we created a digital health platform, Singfit. Carrie: Tell me a little bit about yourself and what brings you to the Connected Health Conference? And yet the industry always seems to want to sort of put us in a cage match.
Beacon’s mobile EEG will join more than a dozen digital healthtechnologies that are already integrated into the Koneksa solution. Koneksa’s extensive commitment to research includes the potential for industry participation in studies.
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.
It is also worth noting that Scotland's healthtech ecosystem is well-supported by a number of government and industry initiatives, such as the Scottish National Health Service (NHS) Scotland Health Innovation Hub and the Life Sciences Scotland industry body. This talent pool is a major asset for the healthtech sector. (1)
The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. SPACs offered a faster and potentially less regulated path to going public, which appealed to many digital health companies. They seem to be well-funded to continue development efforts.
Top Headlines VC firm General Catalyst is creating Health Assurance Transformation Corp., which will partner with 20+ health system partners to guide their transition to value-based care and potentially acquire a health system “where we can demonstrate the blueprint of this transformation for the rest of the industry.”
It is also worth noting that Scotland's healthtech ecosystem is well-supported by a number of government and industry initiatives, such as the Scottish National Health Service (NHS) Scotland Health Innovation Hub and the Life Sciences Scotland industry body. This talent pool is a major asset for the healthtech sector. (1)
The rapid growth of digital health and the potential for disruption in the healthcare industry made it an attractive investment proposition. SPACs offered a faster and potentially less regulated path to going public, which appealed to many digital health companies. They seem to be well-funded to continue development efforts.
The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition.
The healthcare industry is large and growing, and there are many opportunities for innovation. The rise of artificial intelligence and machine learning: Artificial intelligence and machine learning are rapidly transforming the healthcare industry. The increasing regulatory scrutiny: The healthcare industry is heavily regulated.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content